These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21435118)
21. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI. Thom K; Male C; Falger J; Pabinger I Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512 [TBL] [Abstract][Full Text] [Related]
22. Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor. Ashrani AA; Reding MT; Shet A; Osip J; Humar A; Lake JR; Key NS Haemophilia; 2004 Nov; 10(6):735-7. PubMed ID: 15569170 [TBL] [Abstract][Full Text] [Related]
23. Intraocular hemorrhage in a patient with hemophilia. Kobayashi H; Honda Y Metab Ophthalmol; 1984-1985; 8(1):27-30. PubMed ID: 6441096 [TBL] [Abstract][Full Text] [Related]
24. [Prevention of hemorrhage in patients with hemophilia]. Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055 [No Abstract] [Full Text] [Related]
25. Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A. Valentino LA; Recht M; Dipaola J; Shapiro AD; Pipe SW; Ewing N; Urgo J; Bullock T; Simmons M; Deguzman C Haemophilia; 2009 May; 15(3):718-26. PubMed ID: 19298383 [TBL] [Abstract][Full Text] [Related]
26. Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A. Lentz SR; Cerqueira M; Janic D; Kempton C; Matytsina I; Misgav M; Oldenburg J; Ozelo M; Recht M; Rosholm A; Savic A; Suzuki T; Tiede A; Santagostino E Haemophilia; 2016 Sep; 22(5):e445-9. PubMed ID: 27291066 [No Abstract] [Full Text] [Related]
27. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors. Berntorp E; Figueiredo S; Futema L; Pock K; Knaub S; Walter O; Trawnicek L; Römisch J Blood Coagul Fibrinolysis; 2010 Sep; 21(6):577-83. PubMed ID: 20644466 [TBL] [Abstract][Full Text] [Related]
29. Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery. Hay CR; Hellmann A; Dmoszynska A; Baglin T; O'Shaunessey D; Makris M; Shaikh-Zaidi R; Dash CH Haemophilia; 2011 May; 17(3):428-32. PubMed ID: 21371182 [TBL] [Abstract][Full Text] [Related]
30. Experience with prophylaxis in Sweden. Nilsson IM Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738 [No Abstract] [Full Text] [Related]
31. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease. Niessner H; Korninger C Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339 [TBL] [Abstract][Full Text] [Related]
32. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia. Lowe GD Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528 [TBL] [Abstract][Full Text] [Related]
33. Surgical treatment and operative results for patients with transposition of the great arteries. Bastos P; de Leval M; Stark J Acta Med Port; 1980 Dec; Suppl 1():45-58. PubMed ID: 7223503 [No Abstract] [Full Text] [Related]
34. Arterial switch operation for a complex transposition of the great arteries in dextrocardia. Oppido G; Pace Napoleone C; Luca R; Gargiulo G Eur J Cardiothorac Surg; 2005 Jan; 27(1):165-7. PubMed ID: 15621494 [TBL] [Abstract][Full Text] [Related]
35. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting. Björkman S; Folkesson A; Berntorp E Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717 [TBL] [Abstract][Full Text] [Related]
36. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors. Majumdar G; Savidge GF Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476 [TBL] [Abstract][Full Text] [Related]
37. A single centre experience in circumcision of haemophilia patients: Izmir protocol. Yilmaz D; Akin M; Ay Y; Balkan C; Celik A; Ergün O; Kavakli K Haemophilia; 2010 Nov; 16(6):888-91. PubMed ID: 20491959 [TBL] [Abstract][Full Text] [Related]
38. A pharmacokinetic model for factor VIII dosing during active haemorrhage in patients with haemophilia A. Ho AM; Dion P; Karmakar MK; Cheng G; Derrick JL; Chung DC; Tay BA Anaesthesia; 2001 Aug; 56(8):785-90. PubMed ID: 11493246 [TBL] [Abstract][Full Text] [Related]